Riverview Trust Company’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4
Closed -$576 779
2024
Q4
$576 Buy
+4
New +$574 ﹤0.01% 759
2024
Q3
Sell
-90
Closed -$11.3K 851
2024
Q2
$11.3K Hold
90
0.01% 603
2024
Q1
$16.6K Buy
+90
New +$17.1K 0.01% 558
2023
Q4
Sell
-90
Closed -$14.3K 518
2023
Q3
$14.3K Hold
90
0.01% 567
2023
Q2
$12.7K Buy
+90
New +$14.4K 0.01% 640
2022
Q2
Sell
-83
Closed -$16K 834
2022
Q1
$16K Buy
+83
New +$15.8K 0.01% 587

Other funds holding RGEN

Riverview Trust Company's RGEN Position: Q1 2025 in Review

Riverview Trust Company sold out of Repligen (RGEN) in Q1 2025, closing a stake of 4 shares — an estimated $576 sold.

Riverview Trust Company first reported a position in RGEN in Q1 2022 and held it in 6 quarters. The position peaked at $16.6K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Riverview Trust Company reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Riverview Trust Company sold 4 Repligen shares in Q1 2025, an estimated $576.
  • Riverview Trust Company first reported a position in Repligen in Q1 2022 and held it in 6 quarters.
  • Riverview Trust Company's Repligen position peaked at $16.6K in Q1 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.